Summary: Retatrutide, an investigational GLP-1/GIP/glucagon triple agonist, most commonly causes gastrointestinal side effects, and no direct human fertility data currently exist, though indirect reproductive benefits via weight loss are plausible
Those who continued GLP-1 treatment for two or two-and-a-half years before discontinuing for the remainder of the study also gained significant risk reduction (7% and 15%, respectively)
60 Normalized IC 50 values (relative to GLP-1) derived from this competition BRET assay, in intact cells at equilibrium, show that all four modifications at Gly10 of GLP-1 and all four modifications at Gly4 of exendin-4 cause substantial declines in affinity for the GLP-1R relative to the natural agonist
Results should be discussed with your prescriberwhether at Henry Meds or elsewhereto support a more informed treatment conversation
When in doubt, consult an attorney immediately
The mix of protein and fiber supports steady blood sugar and lasting fullness, which is especially helpful when youre eating smaller meals